PT
Protara Therapeutics Inc
🇺🇸XNAS.TARAUnited StatesHealthcare
$3.78USDup +0.02 (+0.53%)OpenDelayed3:30 PM
Price$3.78+0.02 (+0.53%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US74365U1079
- CUSIP
- 04300J107
Company
- Employees
- 46
- Headquarters
- New York, United States
- Website
- https://www.protaratx.com
- CEO
- Mr. Jesse Shefferman
Market
- Shares outstanding
- 59.1M
- Market cap
- $223.38M
Key dates
- Next earnings
- Nov 9, 2026
Highlights
- Market cap
- $230.47M
- EPS LTM
- -$1.15
- P/E LTM
- -3.40
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $0-100%down year on year
- Net income
- -$70.02M-37.66%down year on year
- Gross margin
- Not reported
- Free cash flow
- -$65.16M-45.52%down year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.